I. RESTATEMENT (Tables)

6 Months Ended

Mar. 31, 2020

Accounting Changes and Error Corrections [Abstract]

Balance sheet restatement

	March 31, 2020
BALANCE SHEET	PREVIOUSLY REPORTED			ADJUSTMENT		RESTATED
Finance lease right of use assets	$	12,741,195		$	1,929,551	$	14,670,746
Total assets		34,717,226			1,929,551		36,646,777
Accumulated deficit		(368,108,788	)		1,929,551		(366,179,237	)
Total stockholders' equity		12,208,509			1,929,551		14,138,060
Total liabilities and stockholders' equity		34,717,226			1,929,551		36,646,777

Statement of operations restatement

	Six Months Ended March 31, 2020									Three Months Ended March 31, 2020
STATEMENT OF OPERATIONS	PREVIOUSLY REPORTED			ADJUSTMENT			RESTATED			PREVIOUSLY REPORTED			ADJUSTMENT			RESTATED
Research and development expenses	$	8,598,960		$	112,400		$	8,711,360		$	4,402,347		$	56,200		$	4,458,547
Total operating expenses		13,796,378			112,400			13,908,778			6,960,869			56,200			7,017,069
Operating loss		(13,462,146	)		(112,400	)		(13,574,546	)		(6,662,143	)		(56,200	)		(6,718,343	)
Net loss		(14,486,778	)		(112,400	)		(14,599,178	)		(9,011,618	)		(56,200	)		(9,067,818	)
Net loss available to common shareholders		(14,508,512	)		(112,400	)		(14,620,912	)		(9,033,353	)		(56,200	)		(9,089,552	)
Net loss per share - basic and diluted	$	(0.41	)				$	(0.41	)	$	(0.25	)				$	(0.25	)